Johan E. Lassus
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
Journal: Circulation. Heart failure
Published: August 22, 2024
Circulating levels of miR-20b-5p are associated with survival in cardiogenic shock.
Journal: Journal of molecular and cellular cardiology plus
Published: August 14, 2024
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
Journal: Journal of the American College of Cardiology
Published: December 28, 2022
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment.
Journal: Clinical chemistry
Published: September 19, 2022
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Journal: The New England journal of medicine
Published: August 26, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock.
Journal: European heart journal. Acute cardiovascular care
Published: May 19, 2022
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Journal: European journal of heart failure
Published: May 13, 2022
Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
Journal: European journal of heart failure
Published: January 17, 2022
Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
Journal: Annals of intensive care
Published: March 07, 2021
Last Updated: 09/26/2026